Vimarsana
Biggest News Aggregation in the World

Vincent Oneill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vincent Oneill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vincent Oneill Today - Breaking & Trending Today

Greenock driver acquitted of injuring nurse in collision - Vimarsana News

Greenock driver acquitted of injuring nurse in collision

A Greenock man has been acquitted of driving carelessly and causing an incident which left a theatre charge nurse with two broken feet

BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer's Dementia -April 10, 2024 at 07:01 am EDT - Vimarsana News

BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer's Dementia -April 10, 2024 at 07:01 am EDT

Company plans to initiate trial following recent meeting with FDA No FDA-approved therapies for acute treatment of AAD are currently available NEW HAVEN, Conn., April 10, 2024 -- BioXcel...

Reporters' Notebook: Nov. 13, 2023 – Man up - Vimarsana News

Reporters' Notebook: Nov. 13, 2023 – Man up

A favorite lyric from singer Taylor Swift, born on this date in 1989, "If I was a man/ Then I'd be the man."

Brian J. LaTulip, 89, award-winning character actor renowned for his Irish roles - Vimarsana News

Brian J. LaTulip, 89, award-winning character actor renowned for his Irish roles

April 25, 1934 – Oct. 18, 2023

BioXcel Reports Positive OS Results From Phase 2 Trial Of BXCL701 In Patients With SCNC - Vimarsana News

BioXcel Reports Positive OS Results From Phase 2 Trial Of BXCL701 In Patients With SCNC

BioXcel Therapeutics, Inc. (BTAI), a biopharmaceutical company focused on neuroscience and immuno-oncology, announced Tuesday positive overall survival or OS data from its Phase 2 trial of BXCL701 in combination with KEYTRUDA (pembrolizumab) in patients with small cell neuroendocrine prostate cancer or SCNC.